CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
40.59
10-一月-25 16:45:00
15 分钟延时
股票
-7.91
-16.31%
今日范围
40.04 - 47.56
ISIN
N/A
来源
NASDAQ
-
Crinetics to Highlight Broad Pipeline at ENDO 2023
09 6月 2023 07:30:08 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 5月 2023 16:21:55 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
04 5月 2023 16:05:12 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 4月 2023 16:31:01 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 3月 2023 16:37:50 条件 Nasdaq GlobeNewswire
-
28 2月 2023 16:05:39 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 2月 2023 17:21:42 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference
10 2月 2023 08:01:33 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 1月 2023 16:48:48 条件 Nasdaq GlobeNewswire
-
09 1月 2023 08:01:39 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 12月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Provides Update on CRN04777 Program
28 11月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference
22 11月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
14 11月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 11月 2022 16:30:43 条件 Nasdaq GlobeNewswire
-
13 10月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 10月 2022 16:57:25 条件 Nasdaq GlobeNewswire
-
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
06 10月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer
03 10月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 9月 2022 08:00:01 条件 Nasdaq GlobeNewswire